Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer
NCT00017511
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Head and Neck Cancer
Oral Complications
Radiation Toxicity
Interventions
DRUG:
cevimeline hydrochloride
Sponsor
Daiichi Sankyo